These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 8422833)

  • 41. Serum sialic acid concentration and cardiovascular mortality.
    Lindberg G; Eklund GA; Gullberg B; Råstam L
    BMJ; 1991 Jan; 302(6769):143-6. PubMed ID: 1995133
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plasma and urine sialic acid in non-insulin dependent diabetes mellitus.
    Ozben T; Nacitarhan S; Tuncer N
    Ann Clin Biochem; 1995 May; 32 ( Pt 3)():303-6. PubMed ID: 7632035
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased Serum Chemerin Levels in Diabetic Retinopathy of Type 2 Diabetic Patients.
    Du J; Li R; Xu L; Ma R; Liu J; Cheng J; Zhang Z; Sun H
    Curr Eye Res; 2016; 41(1):114-20. PubMed ID: 25848840
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasma and urine malondialdehyde levels in non-insulin-dependent diabetic patients with and without microalbuminuria.
    Ozben T; Nacitarhan S; Tuncer N
    Int J Clin Lab Res; 1995; 25(3):162-4. PubMed ID: 8562981
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Determinants of progression of microalbuminuria in patients with NIDDM.A prospective study.
    Smulders YM; Rakic M; Stehouwer CD; Weijers RN; Slaats EH; Silberbusch J
    Diabetes Care; 1997 Jun; 20(6):999-1005. PubMed ID: 9167114
    [TBL] [Abstract][Full Text] [Related]  

  • 46. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.
    Pickup JC; Mattock MB; Chusney GD; Burt D
    Diabetologia; 1997 Nov; 40(11):1286-92. PubMed ID: 9389420
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The clinical usefulness of serum fructosamine and HbAlc in patients with NIDDM.
    Lim SY; Jhoo YM; Lee SS; Lee MH; Chung ES; Lee SJ
    Korean J Intern Med; 1989 Jul; 4(2):155-9. PubMed ID: 2486845
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum ferritin as a component of the insulin resistance syndrome.
    Fernández-Real JM; Ricart-Engel W; Arroyo E; Balançá R; Casamitjana-Abella R; Cabrero D; Fernández-Castañer M; Soler J
    Diabetes Care; 1998 Jan; 21(1):62-8. PubMed ID: 9580307
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk factor analyses for macrovascular complication in nonobese NIDDM patients. Multiclinical Study for Diabetic Macroangiopathy (MSDM).
    Ito H; Harano Y; Suzuki M; Hattori Y; Takeuchi M; Inada H; Inoue J; Kawamori R; Murase T; Ouchi Y; Umeda F; Nawata H; Orimo H
    Diabetes; 1996 Jul; 45 Suppl 3():S19-23. PubMed ID: 8674883
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence and risk factors for diabetic retinopathy in the multiethnic population of Mauritius.
    Dowse GK; Humphrey AR; Collins VR; Plehwe W; Gareeboo H; Fareed D; Hemraj F; Taylor HR; Tuomilehto J; Alberti KG; Zimmet PZ
    Am J Epidemiol; 1998 Mar; 147(5):448-57. PubMed ID: 9525531
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum sialic acid in young type-1 diabetic patients.
    Crook M; Cartwright K; Lumb P; Worsley A
    Diabetes Res Clin Pract; 2000 Feb; 47(2):119-22. PubMed ID: 10670911
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased plasma urotensin-II levels are associated with diabetic retinopathy and carotid atherosclerosis in Type 2 diabetes.
    Suguro T; Watanabe T; Kodate S; Xu G; Hirano T; Adachi M; Miyazaki A
    Clin Sci (Lond); 2008 Dec; 115(11):327-34. PubMed ID: 18338983
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of Non-Surgical Periodontal Therapy on the Serum Sialic Acid Levels in Diabetic Patients with Periodontitis.
    Suresh R; Jayachandran P; Fenol A; Biswas R; Krishnan S; Kumar KA; Divakar DD; Vellappally S
    Acta Medica (Hradec Kralove); 2019; 62(3):109-116. PubMed ID: 31663504
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Macrovascular disease is associated with increased plasma apolipoprotein A-IV levels in NIDDM.
    Vergès BL; Lagrost L; Vaillant G; Petit JM; Cohen M; Gambert P; Brun JM
    Diabetes; 1997 Jan; 46(1):125-32. PubMed ID: 8971092
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Blood pressure, lipids, and obesity are associated with retinopathy: the hoorn study.
    van Leiden HA; Dekker JM; Moll AC; Nijpels G; Heine RJ; Bouter LM; Stehouwer CD; Polak BC
    Diabetes Care; 2002 Aug; 25(8):1320-5. PubMed ID: 12145228
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum 8-hydroxy-guanine levels are increased in diabetic patients.
    Shin CS; Moon BS; Park KS; Kim SY; Park SJ; Chung MH; Lee HK
    Diabetes Care; 2001 Apr; 24(4):733-7. PubMed ID: 11315839
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Raised erythrocyte polyamine levels in non-insulin-dependent diabetes mellitus with great vessel disease and albuminuria.
    Seghieri G; Anichini R; Ciuti M; Gironi A; Bennardini F; Franconi F
    Diabetes Res Clin Pract; 1997 Jul; 37(1):15-20. PubMed ID: 9279473
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of glycemic control and blood pressure in the development and progression of nephropathy in elderly Japanese NIDDM patients.
    Tanaka Y; Atsumi Y; Matsuoka K; Onuma T; Tohjima T; Kawamori R
    Diabetes Care; 1998 Jan; 21(1):116-20. PubMed ID: 9538981
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development and progression of diabetic retinopathy in Koreans with NIDDM.
    Kim HK; Kim CH; Kim SW; Park JY; Hong SK; Yoon YH; Lee KU
    Diabetes Care; 1998 Jan; 21(1):134-8. PubMed ID: 9538984
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum sialic acid and ankle versus brachial arterial-pressure ratio in NIDDM.
    Masuda H; Wakabayashi R; Wakabayashi I
    Scand J Clin Lab Invest; 1998 Aug; 58(5):433-39. PubMed ID: 9819193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.